Cite

    Maguire, T. et al. (2016). Patients' experience and expectations of conservative management strategies, anti‐muscarinics and treatment with intravesical onabotulinum toxin for overactive bladder – a qualitative interview study. International journal of urological nursing. 10 (2), pp. 68-77. [Online].